A TIENTS who do not respond to
AZT -the primary AIDS therapeutic drug produced and patented almo
worldwide by Burroughs Wellcome
Co -now have hope.
Studies at the US Nationi Institutes of Health at Bethesd Maryland, show two other drugs . le DDC produced by Hoffmann at Roche Inc and DDI, by Bristol-Meye Squibb Co -are "similarly effectively in slowing the progress of AIDS patients not responding to AZT .
DDI is already officially approved for use by people whose condition is worsens on taking AZT, but only as a supporting drug along with AZT. re Researchers, however, caution DDC be can result in painful nerve damage to arms and legs and Dm can cause stomach upsets and pancreatitis.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.